Consequences of missense mutations for dimerization and turnover of alanine:glyoxylate aminotransferase:: Study of a spectrum of mutations

被引:37
作者
Coulter-Mackie, M. B.
Lian, Q.
机构
[1] Univ British Columbia, Dept Pediat, Childrens & Womens Hlth Ctr, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
基金
加拿大健康研究院;
关键词
hyperoxaluria; mutation; mis-folding; pyridoxal phosphate; alanine glyoxylate aminotransferase;
D O I
10.1016/j.ymgme.2006.07.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alanine:glyoxylate aminotransferase (AGT) is a liver peroxisomal enzyme, deficiency of which results in primary hyperoxaluria type 1 (PH1). More than 65 PH1-related mutations are now documented in the AGT gene (AGXT), of which about 50% are missense. We have generated a spectrum of 15 missense changes including the most common PHI mutation, G170R, and expressed them on the appropriate background of the major or minor allele, in an Escherichia coli overexpression system and in a rabbit reticulocyte transcription/translation system. We have investigated their effects on enzyme activity, dimerization, aggregation, and turnover. The effect of pyridoxal phosphate (PLP) on dimerization and stability was also investigated. Although all 15 mutant AGTs were expressed as intact proteins in E coli, only three: G41R and G41V on the major allele, and the common mutation G170R, resulted in significant amounts of enzymatic activity. Dimerization failure was a frequent observation (13/15) except for G41V and D183N. Dimerization was poor with S187F but was substantially improved with PLP. Proteasome-mediated protein degradation was observed for all the mutations except G41R on the major allele, G41V, D183N, G170R, and S218L. Increases in the stability of the mutant enzymes in the presence of PLP were small; however, G41R on the minor allele showed a direct relationship between its half life and the concentration of PLP. The minor allele AGT product and many of the mutants were subject to a limited non-proteasomal proteolytic cleavage when ATP was depleted. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:349 / 359
页数:11
相关论文
共 57 条
[1]   High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km):: relevance to genetic disease and polymorphisms [J].
Ames, BN ;
Elson-Schwab, I ;
Silver, EA .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (04) :616-658
[2]  
Amoroso A, 2001, J AM SOC NEPHROL, V12, P2072, DOI 10.1681/ASN.V12102072
[3]  
[Anonymous], 1991, HDB VITAMINS
[4]  
BASMAISON O, 2000, HUM MUTAT ONLINE
[5]   ER protein quality control and proteasome-mediated protein degradation [J].
Brodsky, JL ;
McCracken, AA .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 1999, 10 (05) :507-513
[6]   Protein-misfolding diseases and chaperone-based therapeutic approaches [J].
Chaudhuri, TK ;
Paul, S .
FEBS JOURNAL, 2006, 273 (07) :1331-1349
[7]  
Cooper DN., 2001, METABOLIC MOL BASES, P343
[8]   The major allele of the alanine:glyoxylate aminotransferase gene:: Nine novel mutations and polymorphisms associated with primary hyperoxaluria type 1 [J].
Coulter-Mackie, MB ;
Lian, Q ;
Applegarth, D ;
Toone, J .
MOLECULAR GENETICS AND METABOLISM, 2005, 86 (1-2) :172-178
[9]   Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli:: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor [J].
Coulter-Mackie, MB ;
Lian, Q ;
Wong, SG .
PROTEIN EXPRESSION AND PURIFICATION, 2005, 41 (01) :18-26
[10]   Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis [J].
Coulter-Mackie, MB ;
Rumsby, G .
MOLECULAR GENETICS AND METABOLISM, 2004, 83 (1-2) :38-46